Tokyo - Delayed Quote ? JPY PeptiDream Inc. (4587.T) Follow Compare 2,838.00 -4.50 (-0.16%) As of 11:35 AM GMT+9. Market Open. All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations NCC and PeptiDream Announce the First Dosing of 64Cu-PD-32766 in a patient with Clear Cell Renal Cell Carcinoma KAWASAKI, Japan, June 04, 2024--National Cancer Center and PeptiDream Inc.: Business Wire ? 4 months ago PPTDF PeptiDream Announces Expansion of Peptide Discovery Collaboration with Novartis KAWASAKI, Japan, April 30, 2024--PeptiDream Inc., a public Kanagawa, Japan-based biopharmaceutical company (President and CEO: Patrick C. Reid, hereinafter "PeptiDream") (Tokyo: 4587) today announced an expansion of its peptide discovery collaboration with Swiss-based Novartis Pharma AG ("hereinafter Novartis") (NYSE: NVS). Under the multi-program agreement, PeptiDream will use its proprietary Peptide Discovery Platform System ("PDPS?") technology to identify and optimize novel macrocyclic pepti Business Wire ? 5 months ago PPTDF Performance Overview Trailing total returns as of 10/23/2024, which may include dividends or other distributions. Benchmark is Nikkei 225 Return 4587.T Nikkei 225 YTD +90.92% +14.45% 1-Year +124.88% +23.55% 3-Year +11.34% +32.97%
